Table 3.
Intraoperative and postoperative outcomes
| Variable | n (%), mean ± SD | ||
|---|---|---|---|
| Elective PCI during preoperative mitral workup (n = 9) | Past medical history of PCI (n = 8) | p | |
| NeoChord implanted on PML | 4 ± 1 | 3 ± 1 | .17 |
| NeoChord implanted on AML | 3 neochordae in only 1 pt | 1 ± 1 | |
| NeoChord procedural time (min) | 129 ± 30 | 116 ± 22 | .61 |
| Cell‐saved blood volume (ml) | 483 ± 339 | 522 ± 389 | .85 |
| RBC transfusions (U) | |||
| 0 | 7 | 5 | .49 |
| 1 | 0 | 2 | .11 |
| 2 | 2 | 1 | .60 |
| Mechanical ventilation time (h) | 3 ± 1 | 4 ± 7 | .61 |
| MVARC technical success | 9 (100%) | 8 (100%) | |
| MVARC bleeding | |||
| No | 0 | 0 | |
| Minor | 1 (12.5%) | 1 (12.5%) | .93 |
| Major | 0 | 0 | |
| Extensive | 0 | 0 | |
| Life‐threatening or fatal | 0 | 0 | |
| MVARC vascular complications and access‐related complications | 0 | 0 | |
| MVARC neurological events | 0 | 0 | |
| MVARC acute myocardial infarction | 0 | 0 | |
| MVARC acute kidney injury | 1 (12.5%) | 1 (12.5%) | .93 |
| New onset atrial fibrillation | 4 (44.4%) | 3 (37.5%) | .77 |
| Deep wound infection | 0 | 0 | |
| ICU stay days > 1 | 0 | 1 (12.5%) | .27 |
| Total hospital length of stay (days) | 7 ± 2 | 8 ± 2 | .82 |
| Device related death | 0 | 0 | |
| Postoperative in‐hospital mortality | 0 | 1 (12.5%) | .27 |
| MVARC procedural success | 9 (100%) | 7 (87.5%) | .27 |
| MR ≤ mild at discharge | 9 (100%) | 7 (87.5%) | .27 |
Note: variables are expressed as number of patients, n and percentages, %, or mean ± SD.
Abbreviations: AML, anterior mitral leaflet; ICU, intensive care unit; MR, mitral regurgitation; MVARC, Mitral Valve Academic Research Consortium; PML, posterior mitral leaflet; RBC, red blood cells; SD, standard deviation.